DK2003202T3 - G-protein-koblet receptor opreguleret i prostatacancer og anvendelser deraf - Google Patents

G-protein-koblet receptor opreguleret i prostatacancer og anvendelser deraf

Info

Publication number
DK2003202T3
DK2003202T3 DK08165936.9T DK08165936T DK2003202T3 DK 2003202 T3 DK2003202 T3 DK 2003202T3 DK 08165936 T DK08165936 T DK 08165936T DK 2003202 T3 DK2003202 T3 DK 2003202T3
Authority
DK
Denmark
Prior art keywords
prostate cancer
phor
coupled receptor
regulated
applications
Prior art date
Application number
DK08165936.9T
Other languages
English (en)
Inventor
Arthur B Raitano
Daniel E H Afar
Aya Jakobovits
Mary Faris
Rene S Hubert
Steve C Mitchell
Douglas C Saffran
Original Assignee
Agensys Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Agensys Inc filed Critical Agensys Inc
Application granted granted Critical
Publication of DK2003202T3 publication Critical patent/DK2003202T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/08—Drugs for disorders of the urinary system of the prostate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Urology & Nephrology (AREA)
  • Cell Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
DK08165936.9T 1999-10-05 2000-10-05 G-protein-koblet receptor opreguleret i prostatacancer og anvendelser deraf DK2003202T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US15790299P 1999-10-05 1999-10-05
EP00967335A EP1220913B1 (en) 1999-10-05 2000-10-05 G protein-coupled receptor up-regulated in prostate cancer and uses thereof

Publications (1)

Publication Number Publication Date
DK2003202T3 true DK2003202T3 (da) 2012-01-16

Family

ID=22565799

Family Applications (2)

Application Number Title Priority Date Filing Date
DK00967335T DK1220913T3 (da) 1999-10-05 2000-10-05 G-protein-koblet-receptor opreguleret i prostatacancer og anvendelser deraf
DK08165936.9T DK2003202T3 (da) 1999-10-05 2000-10-05 G-protein-koblet receptor opreguleret i prostatacancer og anvendelser deraf

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DK00967335T DK1220913T3 (da) 1999-10-05 2000-10-05 G-protein-koblet-receptor opreguleret i prostatacancer og anvendelser deraf

Country Status (13)

Country Link
EP (2) EP1220913B1 (da)
JP (2) JP4272376B2 (da)
AT (2) ATE524549T1 (da)
AU (2) AU779685B2 (da)
CA (1) CA2385032C (da)
CY (2) CY1110059T1 (da)
DE (1) DE60041073D1 (da)
DK (2) DK1220913T3 (da)
ES (2) ES2371212T3 (da)
HK (1) HK1048494B (da)
IL (1) IL147952A0 (da)
PT (2) PT1220913E (da)
WO (1) WO2001025434A1 (da)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6790631B1 (en) 1999-10-05 2004-09-14 Agensys, Inc. G protein-coupled receptor up-regulated in prostate cancer and uses thereof
US7361338B2 (en) 1999-10-05 2008-04-22 Agensys, Inc. Methods to inhibit growth of prostate cancer cells
US20020048777A1 (en) 1999-12-06 2002-04-25 Shujath Ali Method of diagnosing monitoring, staging, imaging and treating prostate cancer
WO2002092842A2 (en) * 2001-05-15 2002-11-21 Agensys, Inc. Nucleic acids and corresponsing proteins entitled 101p3a11 or phor-1 useful in treatment and detection of cancer
DK1864131T3 (da) * 2005-03-03 2011-10-31 Chemcom Sa Naturlig ligand af G protein koblet receptor RCC356 og anvendelser deraf
JPWO2007119515A1 (ja) * 2006-03-28 2009-08-27 昇志 佐藤 新規腫瘍抗原ペプチド
JP2012196211A (ja) * 2012-04-10 2012-10-18 Japan Science & Technology Agency 前立腺癌マーカポリペプチド、該ポリペプチドに対する抗体、及び該ポリペプチドを利用した前立腺癌の診断方法

Family Cites Families (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4179337A (en) 1973-07-20 1979-12-18 Davis Frank F Non-immunogenic polypeptides
JPS6023084B2 (ja) 1979-07-11 1985-06-05 味の素株式会社 代用血液
US4640835A (en) 1981-10-30 1987-02-03 Nippon Chemiphar Company, Ltd. Plasminogen activator derivatives
US4870009A (en) 1982-11-22 1989-09-26 The Salk Institute For Biological Studies Method of obtaining gene product through the generation of transgenic animals
US4496689A (en) 1983-12-27 1985-01-29 Miles Laboratories, Inc. Covalently attached complex of alpha-1-proteinase inhibitor with a water soluble polymer
US4736866A (en) 1984-06-22 1988-04-12 President And Fellows Of Harvard College Transgenic non-human mammals
EP0206448B1 (en) 1985-06-19 1990-11-14 Ajinomoto Co., Inc. Hemoglobin combined with a poly(alkylene oxide)
US4791192A (en) 1986-06-26 1988-12-13 Takeda Chemical Industries, Ltd. Chemically modified protein with polyethyleneglycol
GB8724885D0 (en) 1987-10-23 1987-11-25 Binns M M Fowlpox virus promotors
US5225538A (en) 1989-02-23 1993-07-06 Genentech, Inc. Lymphocyte homing receptor/immunoglobulin fusion proteins
US4975287A (en) 1989-09-01 1990-12-04 Wm. Wrigley Jr. Company Gum composition containing protein macrocolloids
US5723286A (en) 1990-06-20 1998-03-03 Affymax Technologies N.V. Peptide library and screening systems
AU8221191A (en) 1990-06-27 1992-01-23 Princeton University Probes for detecting mutant p53
US5733731A (en) 1991-10-16 1998-03-31 Affymax Technologies N.V. Peptide library and screening method
CH686982A5 (fr) 1993-12-16 1996-08-15 Maurice Stroun Méthode pour le diagnostic de cancers.
EP0773952B1 (en) 1994-07-20 2003-11-12 The General Hospital Corporation Interaction trap systems for detecting protein interactions
US5919652A (en) 1994-11-09 1999-07-06 The Regents Of The University Of California Nucleic acid molecules comprising the prostate specific antigen (PSA) promoter and uses thereof
ATE352638T1 (de) 1995-04-11 2007-02-15 Gen Hospital Corp REVERSE ßTWO-HYBRIDß-SYSTEME
EP0832122A4 (en) 1995-06-05 1999-08-25 Human Genome Sciences Inc HUMAN G-PROTEIN RECEPTOR HPRAJ70
ES2183166T3 (es) 1996-04-26 2003-03-16 Massachusetts Inst Technology Ensayo de cribado por triple hibrido.
US5925523A (en) 1996-08-23 1999-07-20 President & Fellows Of Harvard College Intraction trap assay, reagents and uses thereof
WO1998016628A1 (en) 1996-10-15 1998-04-23 The Regents Of The University Of California Animal models of human prostate cancer progression
US5846722A (en) 1996-10-16 1998-12-08 Terrapin Technologies, Inc. System to detect small molecule/peptide interaction
EP2305027B1 (en) 1996-12-03 2014-07-02 Amgen Fremont Inc. Transgenic mammals having human Ig loci including plural VH and Vkappa regions and antibodies produced therefrom
AU8555198A (en) * 1997-08-01 1999-02-22 Genset 5' ests for secreted proteins expressed in prostate
KR20010083111A (ko) * 1998-07-14 2001-08-31 길리스 스티브 전립선암의 치료 및 진단을 위한 조성물 및 방법
WO2000020590A2 (en) * 1998-10-06 2000-04-13 Incyte Pharmaceuticals, Inc. G-protein coupled receptor proteins
JP2003521870A (ja) * 1998-10-06 2003-07-22 インサイト・ファーマスーティカルズ・インコーポレイテッド Ｇタンパク質共役受容体タンパク質

Also Published As

Publication number Publication date
ES2316387T3 (es) 2009-04-16
HK1048494A1 (en) 2003-04-04
PT1220913E (pt) 2009-02-16
AU2005201916A2 (en) 2005-08-25
DE60041073D1 (de) 2009-01-22
CA2385032A1 (en) 2001-04-12
AU779685B2 (en) 2005-02-03
CY1112202T1 (el) 2015-12-09
CA2385032C (en) 2013-12-10
ATE417104T1 (de) 2008-12-15
HK1048494B (en) 2009-06-12
DK1220913T3 (da) 2009-03-16
PT2003202E (pt) 2012-01-02
IL147952A0 (en) 2002-08-14
EP1220913B1 (en) 2008-12-10
EP2003202B1 (en) 2011-09-14
AU7755300A (en) 2001-05-10
EP1220913A1 (en) 2002-07-10
JP4272376B2 (ja) 2009-06-03
AU2005201916A1 (en) 2005-06-02
WO2001025434A1 (en) 2001-04-12
ATE524549T1 (de) 2011-09-15
JP4875671B2 (ja) 2012-02-15
EP2003202A2 (en) 2008-12-17
AU2005201916B2 (en) 2008-06-19
JP2009050256A (ja) 2009-03-12
EP2003202A3 (en) 2009-10-21
JP2003511029A (ja) 2003-03-25
ES2371212T3 (es) 2011-12-28
CY1110059T1 (el) 2015-01-14

Similar Documents

Publication Publication Date Title
ATE478952T1 (de) 36p6d5: ausgeschiedenes tumorprotein
ES2202432T3 (es) Factor de crecimiento endotelial vascular b.
EP1488007A4 (en) PERFORMANCE OF GENE EXPRESSION IN BIOPTIC TUMOR TISSUE
EP2444410A3 (en) Brachyury polypeptides and methods for use
ATE364618T1 (de) Antikörper gegen das muc18-antigen
DE69717664D1 (de) Protein e25a, methoden zu dessen herstellung und anwendung
CY1110029T1 (el) Γονιδιο που εκφραζεται στον καρκινο του προστατη
CY1112202T1 (el) Υποδοχεας συζευγμενος προς g πρωτεϊνη θετικως ρυθμισμενος σε καρκινο προστατη και χρησεις αυτου
WO2000012702A3 (en) Human genes differentially expressed in colorectal cancer
HUP0300054A1 (hu) Daganatspecifikus állati fehérjék
Trieb et al. Effects of hyperthermia on heat shock protein expression, alkaline phosphatase activity and proliferation in human osteosarcoma cells
DE60035192D1 (de) Tgf-alpha polypeptide, funktionelle fragmente und verfahren zu ihrer anwendung
ATE425770T1 (de) Kontrastmittel
ATE313647T1 (de) Dickdarm spezifische gene und proteine
WO2003023060A3 (de) Verfahren und kit zur diagnostik oder behandlungskontrolle von brustkrebs
DE602005025231D1 (de) Gene und polypeptide in verbindung mit brustkrebserkrankungen
DE60032333D1 (de) Zusammensetzungen und verfahren zur intraductalen gentherapie
WO2001090157A3 (en) 98p7c3: homeodomain protein highly expressed in various cancers
US6171818B1 (en) Protein having an anti-tumoral effect
WO2003025135A3 (en) Genes associated with malignant neoplasms
Hogen et al. EP008/# 378 Comparative genomic analysis of ovarian clear cell carcinoma patients with and without a second primary malignancy
AU2003247704A8 (en) Methods and compositions for diagnosing hepatocellular carcinoma
WO2002077234A3 (en) Compositions and methods relating to colon specific genes and proteins
CN100516087C (zh) 重组靶向融合蛋白GnRH-TNFαm及其抗肿瘤用途
Carlson COX 2: a promising target for chemotherapy